BIOMAT Database Logo BIOMAT Database Logo

Turbuhaler or nebulizer therapy in severe COPD. 1995

R O'Driscoll

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R O'Driscoll
Terbutaline inhalations by the Turbuhaler as replacement for domiciliary nebulizer therapy in severe chronic obstructive pulmonary disease.
April 1994, Respiratory medicine,
R O'Driscoll
Terbutaline as powder inhalation from Bricanyl Turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction.
September 1989, The European respiratory journal,
R O'Driscoll
Beta agonist therapy: MDI or nebulizer?
September 1991, American pharmacy,
R O'Driscoll
Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
May 2007, The American journal of medicine,
R O'Driscoll
Sympathomimetics in acute severe asthma: inhaled or parenteral, nebulizer or spacer?
April 1989, The European respiratory journal,
R O'Driscoll
[Experience with nebulizer therapy of severe bronchial asthma].
January 2002, Klinicheskaia meditsina,
R O'Driscoll
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.
January 2003, Pulmonary pharmacology & therapeutics,
R O'Driscoll
Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
January 2008, Chronic respiratory disease,
R O'Driscoll
Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.
November 2001, Respiratory medicine,
R O'Driscoll
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD.
September 2022, Nature biotechnology,
Copied contents to your clipboard!